Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
Microbes hijack prostate cancer therapy Androgens such as testosterone and dihydrotestosterone are essential for male reproduction and sexual function. Androgens can also influence the growth of prostate tumor cells, and androgen deprivation therapy (ADT) either by surgical means (castration) or pharmacological approaches (hormone suppression), is the cornerstone of current prostate cancer treatments. Pernigoni et al . found that when the body was deprived of androgens during ADT, the gut microbiome could produce androgens from androgen precursors (see the Perspective by McCulloch and Trinchieri). Gut commensal microbiota in ADT-treated patients or castrated mice produced androgens that were absorbed into the systemic circulation. These microbe-derived androgens appeared to favor the growth of prostate cancer and helped to facilitate development into a castration- or endocrine therapy–resistant state. —PNK
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“polychemotherapy and endocrine therapy (such as androgen deprivation) can modulate the alpha and beta diversities of the microbiota, which have been proposed to affect treatment-related adverse events27,28 as well as drug metabolism and efficacy29,30.”
From Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy (2023) · cites this paper as [29]
In the citing paper
“Nonetheless, we identified that participants with metastatic prostate cancer also cluster in the same cancerassociated clade as those with melanoma. 54”
From Global genetic diversity of human gut microbiome species is related to geographic location and host health (2025) · cites this paper as [54]
In the citing paper
“The original study indicated that some bacteria could produce androgens, such as testosterone, which are associated with adverse cancer outcomes. 54”
From Global genetic diversity of human gut microbiome species is related to geographic location and host health (2025) · cites this paper as [54]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data
McMurdie, P. J., & Holmes, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061217 · Cited by 21,322
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
Sumner, L. W., Amberg, A., Barrett, D., Beale, M. H., Beger, R., Daykin, C. A., Fan, T. W.-M., Fiehn, O., Goodacre, R., Griffin, J. L., et al. (2007) · Metabolomics · doi:10.1007/s11306-007-0082-2 · Cited by 5,368
Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., et al. (2018) · Science · doi:10.1126/science.aan4236 · Cited by 4,812
Quality-filtering vastly improves diversity estimates from Illumina amplicon sequencing
Bokulich, N. A., Subramanian, S., Faith, J. J., Gevers, D., Gordon, J. I., Knight, R., Mills, D. A., & Caporaso, J. G. (2013) · Nature Methods · doi:10.1038/nmeth.2276 · Cited by 4,401
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
Sivan, A., Corrales, L., Hubert, N., Williams, J. B., Aquino-Michaels, K., Earley, Z. M., Benyamin, F. W., Man Lei, Y., Jabri, B., Alegre, M.-L., et al. (2015) · Science · doi:10.1126/science.aac4255 · Cited by 3,888
Cited by
Items 301–326 of 326
Research Progress on Gut Microbiota in Prostate Cancer
佘, 秋. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.163963
Microbiome Landscapes in Squamous Cell Carcinoma Tissue Microenvironments: A Comparative Analysis
Yao, R., Qian, F., Zhao, H., Shen, X., Zhu, Y., & Wang, L. (2026) · Immunity Inflammation and Disease · doi:10.1002/iid3.70406
Mapping prostate cancer pathobiology: A review of genetically engineered mouse models (GEMMs)
Pederzoli, F., Pakula, H., Rodrigues, S. D., Garner, R., Nuzzo, P. V., Bleve, S., Rickman, D. S., Fanelli, G. N., & Loda, M. F. (2026) · Gene · doi:10.1016/j.gene.2026.150131 · Cited by 2
Qu, N., Zhang, M., Ji, Y., Liu, M., Liu, M., & Chen, L. J. (2026) · Immunological Investigations · doi:10.1080/08820139.2025.2590048
朱正勤, Yang, Y., Pan, L., Ma, L., & Fang, L. (2026) · Cancers · doi:10.3390/cancers18081218 · Cited by 1
胡, 科. (2026) · Advances in Clinical Medicine · doi:10.12677/acm.2026.1641594
The cancer–microbiome axis: Mechanisms and emerging therapeutic strategies
Walker, M., Schwarzfischer, M., & Scharl, M. M. (2026) · Seminars in Immunopathology · doi:10.1007/s00281-026-01072-1
Microbial Differences in Prostate Lesions Between Black and White American Men
Verma, S., Gupta, K., Qiao, X., Shen, D. L., MacLennan, G. T., Suryavanshi, M. V., Zhang, L., Miller, A. W., & Gupta, S. (2026) · The Prostate · doi:10.1002/pros.70200 · Cited by 1
Li, J., Hou, J. Y., Liu, H., Fan, S., Wang, Y., Liang, P., Qin, J., Gu, P., Liu, X. J., & Wen, X. (2026) · Dose-Response · doi:10.1177/15593258261444912
Prostate cancer: evading immunity, inspiring therapy
Calì, B., Brina, D., Moscarda, V., Kohl, A., Cetti, F., Bressan, S., & Alimonti, A. (2026) · Trends in cancer · doi:10.1016/j.trecan.2026.07.006
Self-citationAlotaibi, B. S. (2026) · Saudi Pharmaceutical Journal · doi:10.1007/s44446-026-00107-w
From Microbial Ecology to Malignancy: Exploring the Gut Microbiome Across Haematological Disease
Omamuli, R. (2026) · EMJ Hematology · doi:10.33590/emjhematol/j07f9y25
The urinary tract commensal Peptoniphilus spp. encodes a novel 17β-hydroxysteroid dehydrogenase
Binion, B., Ahmad, S., Wang, T., Tang, E., Barnick, B., Olukoya, D., Mbuvi, P., Dutta, D., Erdman, J. W., Gaskins, H. R., et al. (2026) · Applied and Environmental Microbiology · doi:10.1128/aem.00623-26
Lazcano-Ornelas, A., & Tillu, N. (2026) · Lymphatics · doi:10.3390/lymphatics4030046
Wang, K., Tang, Q., Fan, W., & Su, Q. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1882172
Tiwari, S. K., Telatin, A., & Singh, D. (2026) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqag110
Heiskanen, E., Kalinen, S., Chu, R. J., Högerman, M., Lamminen, T., Taimen, P., Jambor, I., Aronen, H. J., Merisaari, H., Sainio, T., et al. (2026) · Scandinavian Journal of Urology · doi:10.2340/sju.v61.46749
Commensal Nakaseomyces glabratus migrates into prostate tumors to accelerate cancer progression
Lai, P., Liu, L., Pernigoni, N., Du, Y., Braga, D., Troiani, M., Attanasio, G., Li, Y., Song, P., Pasquini, E., et al. (2026) · Nature Cancer · doi:10.1038/s43018-026-01229-9 · Cited by 1
Self-citationWang, S., Xu, X., Xu, M., Wei, Y., 乔云晓, Song, X., Xie, C., Zhou, C., & Yuan, F. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10379-2
Pérez‐Castro, S., Carballo, M., Rodríguez-Costas, N., Freire-Rodríguez, A., Daviña‐Núñez, C., Pereira, A. B., Taboada-Rodríguez, P., Pérez-Schoch, M., Cabrera, J. J., Müller‐Arteaga, C., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27198454
Cancer pharmacomicrobiomics: Targeting microbiota to optimize cancer therapy outcomes
Punuri, S. V., Dagar, W., Vodnala, S., Bhyan, B., & Jangra, S. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33206-7.00011-x
Gut microbiota: A key modulator of individualized efficacy and toxicity in cancer therapy
Hou, X., Chen, K., Ran, L., Pu, R., Tong, R., Li, P., Liu, K., Du, H., Liu, Y., & Hou, X. (2026) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2026.101802
The Gut–Prostate Axis: Mechanistic Insights and Nanotechnology Driven Therapeutic Strategies
Mansour, R. M., Salah, A. N., Mageed, S. S. A., El-Sayyad, G. S., Rizk, N. I., Gaballah, M. S. A., zakaria, G., Abdelaziz, M. M., Fahmy, H. A., Shaker, A. A. S., et al. (2026) · Comprehensive physiology · doi:10.1002/cph4.70274
Qiu, C., Zhang, H., Du, Z., Gao, Y., & Dai, L. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1899354
Wang, Y., Zhang, M.-L., & Jin, W. (2026) · Cancer Letters · doi:10.1016/j.canlet.2026.218906
Gihawi, A., Bampalis, A., Subramanian, S., Pan Prostate Cancer Group, Al-Muftah, N., Baena, E., Barrowdale, D., Barton, L., Batra, R. N., Bedő, J., et al. (2026) · npj Biofilms and Microbiomes · doi:10.1038/s41522-026-01140-2
Metadata
- Authors
- Pernigoni, N., Zagato, E., Calcinotto, A., Troiani, M., Mestre, R. P., Calì, B., Attanasio, G., Troisi, J., Minini, M., Mosole, S., Revandkar, A., Pasquini, E., Elia, A. R., Bossi, D., Rinaldi, A., Rescigno, P., Flohr, P., Hunt, J., Neeb, A., Buroni, L., Guo, C., Welti, J., Ferrari, M., Grioni, M., Gauthier, J., Gharaibeh, R. Z., Palmisano, A., Lucchini, G. M., D’Antonio, E., Merler, S., Bolis, M., Grassi, F., Esposito, A., Bellone, M., Briganti, A., Rescigno, M., Theurillat, J.-P., Jobin, C., Gillessen, S., de Bono, J., & Alimonti, A.
- Affiliations
- Institute of Oncology Research (CH)
- Ente Ospedaliero Cantonale (CH)
- Theoreo Srl, Montecorvino Pugliano, 84090 Salerno, Italy.
- Candiolo Cancer Institute (IT)
- Royal Marsden NHS Foundation Trust (GB)
- IRCCS Ospedale San Raffaele (IT)
- University of Florida Health (US)
- Vita-Salute San Raffaele University (IT)
- University of Verona (IT)
- Mario Negri Institute for Pharmacological Research (IT)
- Institute for Research in Biomedicine (CH)
- IRCCS Humanitas Research Hospital, 20089 Rozzano, Milan, Italy.
- Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, UK.
- University of Padua (IT)
- Corresponding author
- Pernigoni, Nicolò
- Zagato, Elena
- Calcinotto, Arianna
- Alimonti, Andrea
- ORCID
- Pernigoni, Nicolò
- Zagato, Elena
- Calcinotto, Arianna
- Mestre, Ricardo Pereira
- Calì, Bianca
- Troisi, Jacopo
- Minini, Mirko
- Mosole, Simone
- Pasquini, Emiliano
- Elia, Angela Rita
- Bossi, Daniela
- Rinaldi, Andrea
- Rescigno, Pasquale
- Flohr, Penny
- Neeb, Antje
- Buroni, Lorenzo
- Guo, Christina
- Welti, Jonathan
- Grioni, Matteo
- Gauthier, Josée
- Gharaibeh, Raad Z.
- Palmisano, Anna
- D’Antonio, Eugenia
- Merler, Sara
- Bolis, Marco
- Grassi, Fabio
- Esposito, Antonio
- Bellone, Matteo
- Briganti, Alberto
- Rescigno, Maria
- Theurillat, Jean-Philippe
- Jobin, Christian
- Gillessen, Silke
- de Bono, Johann
- Alimonti, Andrea
- Venue
- Science
- Published
- 2021-10-08
- Volume
- 374
- Issue
- 6564
- Pages
- 216-224
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W3201967841
- Cited by
- 323
- References
- 55
- Citations by year
- 2026: 55 · 2025: 77 · 2024: 63 · 2023: 55 · 2022: 64 · 2021: 9
- FWCI
- 31.37
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
- Padua Research Archive (University of Padova) (submittedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- National Institute for Health and Care Research (NF-SI-0617-10099)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- prostate cancer, gut microbiota, commensal bacteria, androgen production, endocrine therapy resistance, androgen deprivation therapy, castration, dihydrotestosterone, testosterone
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Host Microbial Interactions, Aged, Aged, 80 and over, Androgen Antagonists, Androgens, Animals, Anti-Bacterial Agents, Bacteria, Humans, Male, Mice, Inbred C57BL, Middle Aged, Neoplasms, Experimental, Symbiosis, Mice, SCID, Mice, Inbred NOD, Prevotella, Xenograft Model Antitumor Assays, Cell Line, Tumor, Mice, Prostatic Neoplasms, Castration-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.